Given that GC33 has been previously shown to localize to GPC3-expressing HCC and the limited treatment options available, we aimed to label GC33 with a cytotoxic alpha particle-emitting isotope to evaluate its therapeutic efficacy in an animal model of HCC [5,13]. The gene discussed is GPC3; the disease is hepatocellular carcinoma.